PCR50 Estimating Meaningful Change Thresholds (MCTs) for EORTC Scales in a Phase 3 Trial in Participants With Inoperable or Metastatic Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer
Jun 1, 2024, 00:00
10.1016/j.jval.2024.03.1930
https://www.valueinhealthjournal.com/article/S1098-3015(24)02045-X/fulltext
Title :
PCR50 Estimating Meaningful Change Thresholds (MCTs) for EORTC Scales in a Phase 3 Trial in Participants With Inoperable or Metastatic Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)02045-X&doi=10.1016/j.jval.2024.03.1930
First page :
Section Title :
Open access? :
No
Section Order :
11045